Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT07190118
Eligibility Criteria:
Inclusion Criteria:
* Children who are under 18 years of age,
* Have been diagnosed with Hemophilia A by a physician,
* Have a factor level of 1% (IU) or less,
* Have inhibitors positive or negative,
* Have no obstacles to starting subcutaneous (emicizumab) treatment,
* Willing to participate in the study
Exclusion Criteria:
\- Children with a history of cerebrovascular bleeding who present any neurological findings that would prevent participation in the study
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
1 Year
Maximum Age:
18 Years
Study:
NCT07190118
Study Brief:
Protocol Section:
NCT07190118